DeDora Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.1K Buy
+38
New +$2.05K ﹤0.01% 398

Other funds holding CRSP

DeDora Capital's CRSP Position: Q3 2026 in Review

DeDora Capital opened a new position in CRISPR Therapeutics (CRSP) in Q3 2026: 38 shares worth $2.1K. The stake represents ﹤0.01% of the portfolio and ranks #398 among its holdings.

503 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.

  • DeDora Capital held 38 shares of CRISPR Therapeutics worth $2.1K as of Q3 2026.
  • CRISPR Therapeutics was a new DeDora Capital position in Q3 2026.
  • CRISPR Therapeutics made up ﹤0.01% of DeDora Capital's portfolio in Q3 2026, its #398 holding.
  • 503 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.

Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.